𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carboplatin plus paclitaxel therapy after docetaxel in men with metastatic castrate resistant prostate cancer

✍ Scribed by Stephanie Jeske; Scott T. Tagawa; Olugbenga Olowokure; Jodi Selzer; Paraskevi Giannakakou; David M. Nanus


Book ID
116956709
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
301 KB
Volume
29
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase 2 study of carboplatin plus doce
✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi